SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 351 JPY | +2.93% |
|
+15.08% | -24.68% |
| May. 14 | Transcript : Sumitomo Pharma Co., Ltd., 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Sumitomo Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 | CI |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 14 M€ | +13.21% | ||
| 0.15% | 62,153 M€ | +17.63% | ||
| 0.13% | 28,050 M€ | +17.67% | - | |
| 0.11% | 1,056 M€ | +4.30% | ||
| 0.10% | 14,619 M€ | +16.71% | - | |
| 0.06% | 57 M€ | +20.14% | ||
| 0.05% | 69 M€ | +17.98% | ||
| 0.03% | 4,931 M€ | +18.92% | ||
| 0.03% | 9,764 M€ | +19.33% | ||
| 0.03% | 17 M€ | +16.94% | - | |
| 0.02% | 138,841 M€ | +18.91% | ||
| 0.02% | 19,753 M€ | +17.73% | - | |
| 0.01% | 775 M€ | -.--% | - | |
| 0.01% | 7 M€ | +5.52% | - | |
| 0.00% | 35 M€ | +5.66% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 36 M€ | +9.83% | - | |
| 0.00% | 414 M€ | +9.92% | - | |
| 0.00% | 40 M€ | +6.57% | - | |
| 0.00% | 324 M€ | +6.70% | - | |
| 0.00% | 32 M€ | +4.00% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
351
JPY
Average target price
323.8
JPY
Spread / Average Target
-7.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.68% | 865M | |
| +48.39% | 765B | |
| -6.13% | 354B | |
| +20.61% | 331B | |
| +10.00% | 299B | |
| +18.87% | 248B | |
| -1.96% | 219B | |
| +11.11% | 216B | |
| +5.80% | 164B | |
| -2.50% | 162B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.
